Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer

The addition of hypoxia modifiers carbogen and nicotinamide (CON) to radiotherapy (RT) improved overall survival (OS) in bladder cancer patients in the BCON phase III clinical trial. We investigate whether expression of hsa-miR-210 in BCON patient samples reflects hypoxia and predicts benefit from h...

Bibliografske podrobnosti
Main Authors:	Irlam-Jones, J, Eustace, A, Denley, H, Choudhury, A, Harris, A, Hoskin, P, West, C
Format:	Journal article
Jezik:	English
Izdano:	Cancer Research UK 2016

Podobne knjige/članki

A gene signature for selecting benefit from hypoxia modification of radiotherapy for high risk bladder cancer patients
od: Yang, L, et al.
Izdano: (2017)

A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
od: Eustace, A, et al.
Izdano: (2013)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial
od: Eustace, A, et al.
Izdano: (2013)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.
od: Eustace, A, et al.
Izdano: (2013)

Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
od: Mutian Lian, et al.
Izdano: (2023-12-01)

Research Advance of Hypoxia-regulated miR-210 in Cancer
od: CAO Zheng, et al.
Izdano: (2018-07-01)

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
od: Camps, C, et al.
Izdano: (2008)

ROD1 is a seedless target gene of hypoxia-induced miR-210.
od: Pasquale Fasanaro, et al.
Izdano: (2012-01-01)

Hypoxia regulated miRNAs in bladder cancer
od: Blick, C, et al.
Izdano: (2012)

The role of hypoxia-inducible MIR-210 in the biology and prognosis of clear cell kidney cancer
od: McCormick, I, et al.
Izdano: (2011)

The effect of hypoxia on PD-L1 expression in bladder cancer
od: Vicky Smith, et al.
Izdano: (2021-11-01)

Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer.
od: Ailin Qu, et al.
Izdano: (2014-01-01)

Hypoxia-induced miR-210 modulates the inflammatory response and fibrosis upon acute ischemia
od: Zaccagnini Germana, et al.
Izdano: (2021-05-01)

Hypoxia-preconditioned WJ-MSC spheroid-derived exosomes delivering miR-210 for renal cell restoration in hypoxia-reoxygenation injury
od: Reyhaneh Toghiani, et al.
Izdano: (2024-07-01)

hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer.
od: Gee, H, et al.
Izdano: (2010)

Circulating hypoxia-dependent miR-210 is increased in clinical sepsis subtypes: A cohort study
od: Rachel E Powell, et al.
Izdano: (2022-10-01)

Retraction: Hypoxia-Inducible MiR-210 Is an Independent Prognostic Factor and Contributes to Metastasis in Colorectal Cancer.
od: PLOS ONE Editors
Izdano: (2020-01-01)

miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
od: McCormick, R, et al.
Izdano: (2013)

MiR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis
od: McCormick, R, et al.
Izdano: (2013)

Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis
od: Hao Cheng, et al.
Izdano: (2020-06-01)

miR-210 Protects Renal Cell Against Hypoxia-induced Apoptosis by Targeting HIF-1 Alpha
od: Li-Li Liu, et al.
Izdano: (2017-10-01)

Hypoxia-Induced miR-210 Promotes Endothelial Cell Permeability and Angiogenesis via Exosomes in Pancreatic Ductal Adenocarcinoma
od: Guo Wu, et al.
Izdano: (2022-01-01)

miR-210 Regulates Apoptotic Cell Death during Cellular Hypoxia and Reoxygenation in a Diametrically Opposite Manner
od: Gurdeep Marwarha, et al.
Izdano: (2021-12-01)

A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trialResearch in context
od: Tim A.D. Smith, et al.
Izdano: (2024-03-01)

Gingerol ameliorates neuronal damage induced by hypoxia‐reoxygenation via the miR‐210/brain‐derived neurotrophic factor axis
od: Yang Zhai, et al.
Izdano: (2022-04-01)

Mono-(2-ethylhexyl) phthalate induces trophoblast hypoxia and mitochondrial dysfunction through HIF-1α-miR-210-3p axis in HTR-8/SVneo cell line
od: Sunitha Meruvu, et al.
Izdano: (2024-01-01)

Hypoxia-Induced MicroRNA-210 Targets Neurodegenerative Pathways
od: Michelle E. Watts, et al.
Izdano: (2018-03-01)

Paracrine effects of mir-210-3p on angiogenesis in hypoxia-treated c-kit-positive cardiac cells
od: Louyi Shen, et al.
Izdano: (2023-12-01)

Hypoxia‐induced miR‐210‐3p expression in lung adenocarcinoma potentiates tumor development by regulating CCL2 mediated monocyte infiltration
od: Leena Arora, et al.
Izdano: (2024-05-01)

Hypoxia and hypoxia mimetics differentially modulate histone post-translational modifications
od: Hsu, K-F, et al.
Izdano: (2020)

Hypoxia-induced miR-15a promotes mesenchymal ablation and adaptation to hypoxia during lung development in chicken.
od: Rui Hao, et al.
Izdano: (2014-01-01)

Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer
od: Blick, C, et al.
Izdano: (2013)

Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer.
od: Blick, C, et al.
Izdano: (2013)

MiR-155 deficiency and hypoxia results in metabolism switch in the leukemic B-cells
od: Elena Golovina, et al.
Izdano: (2024-07-01)

Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis
od: Knowles, H, et al.
Izdano: (2001)

Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis.
od: Knowles, H, et al.
Izdano: (2001)

Hypoxia and hypoxia mimetics differentially modulate histone post-translational modifications
od: Kuo-Feng Hsu, et al.
Izdano: (2021-01-01)

Roles of miR-210 in the pathogenesis of pre-eclampsia
od: Jiyun Li, et al.
Izdano: (2018-12-01)

Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer.
od: Yongmei Yang, et al.
Izdano: (2015-01-01)

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma.
od: Betts, G, et al.
Izdano: (2013)